Tsukuba, Japan

Isshin Tanaka

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isshin Tanaka. Retrieved from https://idiyas.com/inventor/isshin-tanaka-z3otjayi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Isshin Tanaka in Antifungal Compounds

Introduction

Isshin Tanaka is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of antifungal research. His work focuses on developing compounds that exhibit antifungal activity, which are essential in treating and preventing fungal infectious diseases.

Latest Patents

Isshin Tanaka holds 1 patent for a compound characterized by a specific chemical structure that demonstrates antifungal properties. This innovation is crucial for addressing various fungal infections, thereby improving health outcomes for affected individuals.

Career Highlights

Tanaka is associated with Sankyo Company, Limited, where he continues to advance his research in antifungal compounds. His dedication to innovation in this field has positioned him as a key figure in pharmaceutical development.

Collaborations

Throughout his career, Tanaka has collaborated with esteemed colleagues such as Tatsuya Yano and Masatoshi Inukai. These partnerships have fostered a collaborative environment that enhances the research and development of effective antifungal treatments.

Conclusion

Isshin Tanaka's contributions to antifungal research through his patented compounds highlight the importance of innovation in addressing health challenges. His work continues to impact the field positively, paving the way for future advancements in antifungal therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…